INSMED INC (1INSM.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:1INSM • US4576693075
132 EUR
-6 (-4.35%)
Last: Jan 29, 2026, 07:00 PM
Taking everything into account, 1INSM scores 3 out of 10 in our fundamental rating. 1INSM was compared to 85 industry peers in the Biotechnology industry. While 1INSM seems to be doing ok healthwise, there are quite some concerns on its profitability. 1INSM is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- In the past year 1INSM has reported negative net income.
- 1INSM had a negative operating cash flow in the past year.
- In the past 5 years 1INSM always reported negative net income.
- 1INSM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -50.15%, 1INSM is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
- 1INSM has a Return On Equity (-125.20%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.15% | ||
| ROE | -125.2% | ||
| ROIC | N/A |
ROA(3y)-43.52%
ROA(5y)-40.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Gross Margin value of 76.54%, 1INSM is doing good in the industry, outperforming 64.71% of the companies in the same industry.
- In the last couple of years the Gross Margin of 1INSM has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for 1INSM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.05%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
- 1INSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for 1INSM has been increased compared to 1 year ago.
- The number of shares outstanding for 1INSM has been increased compared to 5 years ago.
- The debt/assets ratio for 1INSM has been reduced compared to a year ago.
2.2 Solvency
- 1INSM has an Altman-Z score of 10.71. This indicates that 1INSM is financially healthy and has little risk of bankruptcy at the moment.
- 1INSM has a better Altman-Z score (10.71) than 89.41% of its industry peers.
- 1INSM has a Debt/Equity ratio of 0.77. This is a neutral value indicating 1INSM is somewhat dependend on debt financing.
- The Debt to Equity ratio of 1INSM (0.77) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 10.71 |
ROIC/WACCN/A
WACC8.61%
2.3 Liquidity
- A Current Ratio of 4.63 indicates that 1INSM has no problem at all paying its short term obligations.
- 1INSM's Current ratio of 4.63 is fine compared to the rest of the industry. 1INSM outperforms 77.65% of its industry peers.
- A Quick Ratio of 4.34 indicates that 1INSM has no problem at all paying its short term obligations.
- With a decent Quick ratio value of 4.34, 1INSM is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.63 | ||
| Quick Ratio | 4.34 |
3. Growth
3.1 Past
- 1INSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.53%.
- 1INSM shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.34%.
- The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.8%
Revenue 1Y (TTM)30.34%
Revenue growth 3Y24.49%
Revenue growth 5Y21.65%
Sales Q2Q%52.36%
3.2 Future
- 1INSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.44% yearly.
- The Revenue is expected to grow by 67.90% on average over the next years. This is a very strong growth
EPS Next Y-11.32%
EPS Next 2Y19.15%
EPS Next 3Y22.09%
EPS Next 5Y26.44%
Revenue Next Year51.41%
Revenue Next 2Y90%
Revenue Next 3Y85.75%
Revenue Next 5Y67.9%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for 1INSM. In the last year negative earnings were reported.
- Also next year 1INSM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as 1INSM's earnings are expected to grow with 22.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.15%
EPS Next 3Y22.09%
5. Dividend
5.1 Amount
- No dividends for 1INSM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INSMED INC / 1INSM.MI FAQ
Can you provide the ChartMill fundamental rating for INSMED INC?
ChartMill assigns a fundamental rating of 3 / 10 to 1INSM.MI.
Can you provide the valuation status for INSMED INC?
ChartMill assigns a valuation rating of 1 / 10 to INSMED INC (1INSM.MI). This can be considered as Overvalued.
Can you provide the profitability details for INSMED INC?
INSMED INC (1INSM.MI) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for 1INSM stock?
The Earnings per Share (EPS) of INSMED INC (1INSM.MI) is expected to decline by -11.32% in the next year.